Plus Therapeutics Inc (PSTV)
NASDAQ · Healthcare
Plus Therapeutics Inc Operating Income 2009–2025
Plus Therapeutics Inc annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Plus Therapeutics Inc operating income for the quarter ending March 31, 2026 was -7.1 M, a 101.33% increase year-over-year.
- Plus Therapeutics Inc operating income for the twelve months ending March 31, 2026 was -16.7 M, a 28.66% increase year-over-year.
- Plus Therapeutics Inc annual operating income for 2025 was -15.3 M, a 4.10% increase from 2024.
- Plus Therapeutics Inc annual operating income for 2024 was -14.7 M, a 10.31% increase from 2023.
- Plus Therapeutics Inc annual operating income for 2023 was -13.3 M, a 52.03% increase from 2018.
- Plus Therapeutics Inc annual operating income for 2018 was -8.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Plus Therapeutics Inc Operating Income — FAQ
Plus Therapeutics Inc (PSTV) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Plus Therapeutics Inc's operating income?
Plus Therapeutics Inc (PSTV) reported operating income of -$15M for fiscal 2025.
Where can I see PSTV's operating income history?
The chart and table above show Plus Therapeutics Inc's operating income by year and by quarter, including the growth rate.